Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity

Gaens, Katrien HJ., Stehouwer, Coen DA., Schalkwijk, Casper G. · 2013 · Current Opinion in Lipidology

Abstract

PURPOSE OF REVIEW: To highlight the potential importance of advanced glycation endproducts (AGEs) and advanced-lipoxidation endproducts (ALEs) in obesity and obesity-related complications, and the contribution of the receptor for advanced glycation endproducts (RAGE) and the glyoxylase defense system therein. RECENT FINDINGS: Formation of AGEs/ALEs and its precursors, including methylglyoxal (MGO), are increased in conditions characterized by hyperglycemia, hyperlipidemia and enhanced oxidative stress. This metabolic profile is generally considered typical for obesity. Increased plasma and/or tissue levels of MGO and of specific AGEs/ALEs, such as N(ε)-(carboxymethyl)lysine (CML), in obesity have recently been described. In addition to increased formation, the suppressed defense system in obesity against AGEs/ALEs formation, that is, the glyoxylase system, will further contribute to AGEs/ALEs formation in obesity. AGEs/ALEs are not inert. In-vitro studies showed that AGEs induced the production of inflammatory mediators in adipocytes and macrophages via RAGE activation, which may subsequently contribute to the development of obesity-related complications. SUMMARY: The recognition of an enhanced AGEs/ALEs formation in adipose tissue and the biological consequences thereof may lead to a further understanding of underlying mechanisms in dysregulated production of adipokines in obesity.

Overview

Integrity signals

Registry

Crossref · 10.1097/mol.0b013e32835aea13

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 64 references

Research works printed but not linked: 1

  1. Song, 2007, RAGE regulates obesity and hyperglycmia induced by high-fat feeding in mice., Diabetes, 56, A451

Cited by

See all 171

Metadata

Authors
Gaens, K. H., Stehouwer, C. D., & Schalkwijk, C. G.
Affiliations
Maastricht University Medical Centre (NL)
Corresponding author
Schalkwijk, Casper G.
Venue
Current Opinion in Lipidology
Published
2013-02
Volume
24
Issue
1
Pages
4-11
ISSN
0957-9672 (ISSN-L)
OpenAlex
W2048970664
Cited by
166
References
64
Citations by year
2026: 7 · 2025: 10 · 2024: 11 · 2023: 10 · 2022: 13 · 2021: 13 · 2020: 9 · 2019: 14 · 2018: 10 · 2017: 16 · 2016: 12 · 2015: 19 · 2014: 17 · 2013: 5
FWCI
1.84
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Lipidology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (submittedVersion)
Funders
  • Nierstichting
  • Center for Translational Molecular Medicine
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Dermatology › Skin Diseases and Diabetes
Keywords
advanced glycation end products, receptor for advanced glycation end products, obesity, methylglyoxal, oxidative stress, hyperglycemia, hyperlipidemia, adipose tissue, inflammation, adipokines, obesity complications
MeSH terms
Receptor for Advanced Glycation End Products, Adipose Tissue, Humans, Hyperlipidemias, Lactoylglutathione Lyase, Macrophages, Obesity, Pyruvaldehyde, Receptors, Immunologic, Lipid Peroxidation, Signal Transduction, Glycation End Products, Advanced, Adipocytes, Oxidative Stress

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity. https://app.cochat.ai/papers/10.1097/mol.0b013e32835aea13
The paper
Gaens, K. H., Stehouwer, C. D., & Schalkwijk, C. G. (2013). Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity. Current Opinion in Lipidology. https://doi.org/10.1097/mol.0b013e32835aea13

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.